National Institutes of Health: Panic Disorder trials
The registry lists 11 Panic Disorder studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 1Phase 4 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- CO2 Inhalation and Risk for Panic DisorderTerminatedNCT00930657
- Neurobiological Mechanisms in Panic DisorderCompletedNCT00103987
- Ventilatory Physiology in Children at Risk for AnxietyCompletedNCT00101777
- Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQCompletedNCT00088738Phase 1
- Genetic Causes of Panic DisorderCompletedNCT00083265
- Evaluation of Clonazepam and Paroxetine for Panic Disorder With DepressionCompletedNCT00031317Phase 4
- Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress DisorderCompletedNCT00025974
- Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With AnxietyCompletedNCT00004373Phase 2
- Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without AgoraphobiaCompletedNCT00004367Not applicable
- Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular DysfunctionCompletedNCT00004366Not applicable
- Evaluation of the Genetics of Bipolar DisorderCompletedNCT00001174